179 related articles for article (PubMed ID: 31035691)
1. Identification of FDA-Approved Drugs with Activity against Stationary Phase
Li T; Feng J; Xiao S; Shi W; Sullivan D; Zhang Y
Antibiotics (Basel); 2019 Apr; 8(2):. PubMed ID: 31035691
[No Abstract] [Full Text] [Related]
2. Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro.
Zheng X; Ma X; Li T; Shi W; Zhang Y
BMC Microbiol; 2020 Apr; 20(1):87. PubMed ID: 32276590
[TBL] [Abstract][Full Text] [Related]
3. Essential Oils with High Activity against Stationary Phase
Ma X; Shi W; Zhang Y
Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31801196
[No Abstract] [Full Text] [Related]
4. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.
Feng J; Wang T; Shi W; Zhang S; Sullivan D; Auwaerter PG; Zhang Y
Emerg Microbes Infect; 2014 Jul; 3(7):e49. PubMed ID: 26038747
[TBL] [Abstract][Full Text] [Related]
5. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library.
Feng J; Shi W; Zhang S; Sullivan D; Auwaerter PG; Zhang Y
Front Microbiol; 2016; 7():743. PubMed ID: 27242757
[TBL] [Abstract][Full Text] [Related]
6. Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.
Feng J; Weitner M; Shi W; Zhang S; Sullivan D; Zhang Y
Antibiotics (Basel); 2015 Sep; 4(3):397-410. PubMed ID: 27025631
[TBL] [Abstract][Full Text] [Related]
7. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
Feng J; Auwaerter PG; Zhang Y
PLoS One; 2015; 10(3):e0117207. PubMed ID: 25806811
[TBL] [Abstract][Full Text] [Related]
8. The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Wolfson C; Branley J; Gottlieb T
J Antimicrob Chemother; 1996 Dec; 38(6):963-8. PubMed ID: 9023643
[TBL] [Abstract][Full Text] [Related]
9. Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro.
Feng J; Zhang S; Shi W; Zhang Y
Antibiotics (Basel); 2017 Mar; 6(1):. PubMed ID: 28327498
[TBL] [Abstract][Full Text] [Related]
10. Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae.
Musso D; Drancourt M; Raoult D
J Antimicrob Chemother; 1995 Jul; 36(1):101-8. PubMed ID: 8537257
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility by Etest of Bartonella henselae isolated from cats and human in Japan.
Tsuneoka H; Yanagihara M; Nojima J; Ichihara K
J Infect Chemother; 2010 Dec; 16(6):446-8. PubMed ID: 20567991
[TBL] [Abstract][Full Text] [Related]
12. Identification of essential oils with activity against stationary phase Staphylococcus aureus.
Xiao S; Cui P; Shi W; Zhang Y
BMC Complement Med Ther; 2020 Mar; 20(1):99. PubMed ID: 32209108
[TBL] [Abstract][Full Text] [Related]
13. Pathogenicity and treatment of Bartonella infections.
Angelakis E; Raoult D
Int J Antimicrob Agents; 2014 Jul; 44(1):16-25. PubMed ID: 24933445
[TBL] [Abstract][Full Text] [Related]
14. [Seroprevalence of Bartonella henselae and Bartonella quintana infections in Poland in 1998-2001].
Podsiadły E; Sokołowska E; Tylewska-Wierzbanowska S
Przegl Epidemiol; 2002; 56(3):399-407. PubMed ID: 12608089
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and use of a nested polymerase chain reaction assay in cats experimentally infected with Bartonella henselae genotype I and Bartonella henselae genotype II.
Roy AF; Corstvet RE; Tapp RA; Oreilly KL; Cox HU
J Vet Diagn Invest; 2001 Jul; 13(4):312-22. PubMed ID: 11478603
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Polish Bartonella henselae strains.
Podsiadły E; Zabicka D; Demkow U; Hryniewicz W; Tylewska-Wierzbanowska S
Pol J Microbiol; 2012; 61(2):143-5. PubMed ID: 23163214
[TBL] [Abstract][Full Text] [Related]
17. First isolation and genotyping of Bartonella henselae from a cat living with a patient with cat scratch disease in Southeast Europe.
Stepanić M; Duvnjak S; Reil I; Špičić S; Kompes G; Beck R
BMC Infect Dis; 2019 Apr; 19(1):299. PubMed ID: 30940084
[TBL] [Abstract][Full Text] [Related]
18. Identification of Essential Oils with Strong Activity against Stationary Phase
Feng J; Shi W; Miklossy J; Tauxe GM; McMeniman CJ; Zhang Y
Antibiotics (Basel); 2018 Oct; 7(4):. PubMed ID: 30332754
[TBL] [Abstract][Full Text] [Related]
19. Development of a Specific and Sensitive Enzyme-Linked Immunosorbent Assay as an
Jost M; Latz A; Ballhorn W; Kempf VAJ
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257897
[No Abstract] [Full Text] [Related]
20. The expanding spectrum of Bartonella infections: II. Cat-scratch disease.
Bass JW; Vincent JM; Person DA
Pediatr Infect Dis J; 1997 Feb; 16(2):163-79. PubMed ID: 9041596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
